Aemetis, Inc

AMTX Basic Materials Specialty Chemicals

Aemetis, Inc’s revenue for fiscal 2025 (year ended December 2025) was $197.6 million, down 26.2% from fiscal 2024.

Revenue
+48.9%
EPS
+118.9%
Free cash flow
+269.0%
Total debt
+12.6%

Quarter to September 2026, against a year earlier

1.62 0.11 −6.36%
Market cap
$124.9M
P/E
0.0×
Fwd P/E
−1.4×
Dividend yield
—
F-score
4/9
Altman Z
−4.66
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Sold, $m 0.02
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — 1 — — — — —
Insider Ownership 7.37%

Capital & Financial Ratios $m

Size
Market Cap 124.85
Revenue ttm 248.78
Net income ttm (31.20)
Free cash flow ttm (36.58)
Net debt Q 371.59
Valuation
P/E 0.00
Forward P/E (1.43) (negative: loss-making)
Price / sales 0.47
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.00
Financial health
Current ratio Q 0.07 (below 1: weak)
Debt / equity Q (1.19) (negative: negative equity)
Interest coverage Q 1.47
Growth
Revenue growth Q +48.93% (above 0%: growing)
Operating income growth Q +345.09% (above 0%: growing)
EPS, this year +31.53% (at or above 15%: strong)
EPS, next year A +45.09% (at or above 15%: strong)
Revenue, next year A +31.41% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +35.09% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 56.93%
10-year low 10-year high
EV/Sales against its own 10 years 66.68%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 3 1 5 3
Receivables 9 14 0 —
Inventory 18 25 12 13
Other 3 2 8 3
36 45 27 29
2023 2024 2025 Q'26
Payables 32 33 23 37
ST’ Debt 14 64 279 316
Other 15 20 30 26
84 144 371 440

Compound Annual Growth %

10y 5y 3y
Sales 3.03% 3.60% (8.33%)
Cash Flow 0.00% 5.64% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value 0.00% 0.00% 0.00%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 (0.33) (0.13) 0.07 — —
’25 (0.47) (0.41) (0.37) (0.08) (1.28)
’24 (0.58) (0.66) (0.38) (0.36) (1.91)
’23 (0.73) (0.68) 0.73 (0.64) (1.22)
’22 (0.54) (0.01) (2.01) (0.63) (3.12)
’21 (0.69) (0.34) (0.55) (0.03) (1.54)
’20 (0.58) 0.10 (0.59) (0.68) (1.74)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 55 63 88 — —
’25 43 52 59 43 198
’24 73 67 81 47 268
’23 2 45 69 71 187
’22 52 66 72 67 257
’21 43 55 50 64 212
’20 39 48 41 37 166
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (11) (2) 22 — —
’25 0 (6) 3 6 3
’24 (10) (5) (5) (13) (33)
’23 (11) (3) (6) 34 14
’22 (8) 2 (10) (7) (23)
’21 (14) (4) (2) (1) (21)
’20 1 4 2 (5) 2
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (17) (10) 2 — —
’25 (2) (9) (1) (11) (23)
’24 (14) (10) (9) (19) (53)
’23 (19) (5) (15) 19 (19)
’22 (18) (11) (16) (17) (62)
’21 (21) (11) (8) (9) (47)
’20 (2) (2) (4) (9) (17)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.5
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 143 150 172 202 166 212 257 187 268 198 249 +3.6% 260 374 528 +38.7%
Gross margin, % 8.10 2.25 3.15 6.29 6.66 3.75 (2.16) 1.08 (0.22) (0.39) 21.49 (8.5) pt
EBT (16) (32) (36) (38) (38) (47) (107) (100) (98) (96) (43) +22.3%
EBT margin, % (10.92) (21.15) (21.15) (18.98) (22.73) (22.30) (41.60) (53.64) (36.75) (48.45) (17.19) (37.5) pt
Net income (16) (32) (36) (39) (37) (47) (108) (46) (88) (77) (31) +19.4%
Per share, $
Per share, $ Revenue 7.24 7.57 8.47 9.87 7.88 6.91 7.42 4.91 5.83 3.29 3.43 (8.4%)
Earnings (0.79) (1.53) (1.63) (1.75) (1.74) (1.54) (3.12) (1.22) (1.91) (1.28) (0.47) +5.5%
Cash flow 0.02 (0.44) (0.27) (0.10) 0.12 (0.67) (0.66) 0.36 (0.72) 0.05 0.21 +12.5%
Capex (0.03) (0.06) (0.20) (0.42) (0.92) (0.87) (1.13) (0.87) (0.44) (0.43) (0.72) +33.7%
Free cash flow (0.01) (0.49) (0.47) (0.52) (0.80) (1.54) (1.79) (0.51) (1.16) (0.38) (0.50) +45.5%
Book value (2.52) (4.03) (5.71) (7.54) (8.79) (3.92) (5.84) (5.70) (5.75) (5.12) (4.33) +8.2%
Shares, m 20 20 20 20 21 31 35 38 46 60 68 +13.1%
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
P/S 0.21 0.08 0.07 0.08 0.32 1.78 0.53 0.97 0.46 0.42 0.47 0.5
P/B 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
EV/Sales 0.92 1.01 1.00 1.00 1.61 2.57 1.33 2.41 1.62 2.13 1.97 1.6
EV/FCF (508.89) (15.43) (17.89) (19.02) (15.82) (11.50) (5.48) (23.35) (8.16) (18.54) (13.37) (64.4)
Cash, $m
Cash, $m Operating cash flow 0 (9) (6) (2) 2 (21) (23) 14 (33) 3 15 +27.3%
Capex (1) (1) (4) (9) (19) (27) (39) (33) (20) (26) (52) +51.2%
Free cash flow 0 (10) (10) (11) (17) (47) (62) (19) (53) (23) (37) +64.5%
Balance, $m
Balance, $m Working capital (20) (25) (32) (45) (94) (45) (70) (48) (99) (344) (411) +37.1%
Net debt 101 140 159 185 214 166 205 269 310 338 372 +14.4%
Shareholders’ equity (50) (80) (116) (154) (185) (120) (202) (217) (264) (307) (314) +22.4%
Returns, %
Returns, % ROA (19.43) (35.20) (35.47) (37.26) (32.58) (32.97) (58.57) (20.61) (34.83) (29.66) (11.28) (10.2) pt
ROIC (0.96) (12.71) (15.72) (10.12) (12.76) (21.41) (647.80) (45.27) (54.39) (74.29) 19.40 (73.3) pt
ROE 36.74 46.73 33.79 26.46 21.62 30.92 66.91 22.17 36.41 26.98 10.08 (9.8) pt
People
People Employees 144 140 166 160 164 158 168 205 223 220 — +4.8%
Revenue/emp, $m 0.99 1.07 1.03 1.26 1.01 1.34 1.53 0.91 1.20 0.90 — (1.1%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

Aemetis, Inc vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ALTO Alto Ingredients, Inc. $284.7M 5.4× 9.7× +12.48% (above 0%: growing) +200.00% (above 0%: growing) +1,443.92% (above 0%: growing) 6.77% 3.51% Compare
FF FutureFuel Corp. $236.9M — (loss-making) — (loss-making) +120.69% (above 0%: growing) n/m +4,245.38% (above 0%: growing) 19.08% 14.29% Compare
CMT Core Molding Technologies Inc $186.3M 25.6× 44.8× +54.42% (above 0%: growing) −18.18% (below 0%: shrinking) −3,170.52% (below 0%: shrinking) 14.83% 1.76% Compare
HDSN Hudson Technologies, Inc. $172.1M — (loss-making) 33.2× −19.71% (below 0%: shrinking) −82.14% (below 0%: shrinking) +43.42% (above 0%: growing) 24.91% 5.47% Compare
AMTX Aemetis, Inc $124.9M — (loss-making) — (loss-making) +48.93% (above 0%: growing) n/m +269.01% (above 0%: growing) 33.43% 23.65%
ACNT Ascent Industries Co. $122.4M — (loss-making) — (loss-making) +37.61% (above 0%: growing) n/m −97.54% (below 0%: shrinking) 21.62% (1.02%) Compare
FEAM 5E Advanced Materials, Inc. $93.8M — (loss-making) — — n/m +17.79% (above 0%: growing) 0.00% 0.00% Compare
NTIC Northern Technologies International Corporation $72.0M — (loss-making) 188× +12.59% (above 0%: growing) n/m +327.52% (above 0%: growing) 33.63% 2.13% Compare
CITR CitroTech Inc. $58.7M — (loss-making) — (loss-making) −59.18% (below 0%: shrinking) n/m −30.95% (below 0%: shrinking) 3.21% (1,244.78%) Compare
Median of peers $147.3M — 39.0× +12.59% −18.18% +30.61% 16.95% 1.95%

All 61 Specialty Chemicals stocks →

Pay and ownership Proxy statement filed 7 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 1.87m 1.87m 56.00
2024 1.64m 1.64m 108.00
2023 1.76m 1.76m 210.00
2022 460.00k 460.00k 159.00
2021 2.43m 2.43m 494.00
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Read the proxy statement

Aemetis, Inc (AMTX) Latest News

5 Nov

Impact 4 · · The Motley Fool transcript
Impact 3 · · MarketBeat transcript
Impact 3 · · Associated Press
Impact 3 · · GlobeNewswire

22 Oct

Impact 4 · · GlobeNewswire

13 Aug

Impact 4 · · The Motley Fool transcript

12 May

7 May

Impact 4 · · The Motley Fool transcript
Impact 4 · · GlobeNewswire
Impact 3 · · MarketBeat

12 Mar

Impact 4 · · Moby
Impact 4 · · MarketBeat
Impact 4 · · The Motley Fool transcript
Impact 3 · · Associated Press Finance
stockrow.com/AMTX · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com